✨
AI Summary
- Dupilumab pregnancy registry shows no increased birth defect risk.
- Tina Chambers, PhD, MPH, presented 7-year prospective data at EADV.
- Reassuring findings for pregnant patients using dupilumab.
Guests on This Episode
TC
Tina Chambers
1 podcast appearance